LIVER/SPLEEN

 

liver/spleen (normal #1)

Clinical Indications: 50 year old with a 3 year history of increasing LFT’s w/ family history of liver disease; patient has a history of liver damage and cirrhosis.

Dose: 5mCi Tc-99m-albumin colloid given i.v.

Results: normal liver/spleen scan; liver and spleen are within normal size limits; no evidence of hepatocellular dysfunction.

  


liver/spleen (normal #2)

Clinical Indications: 48 year old male with end-stage renal disease due to polycystic kidney disease.

Dose: 5mCi Tc-99m-albumin colloid given i.v.

Results: normal liver/spleen scan with no hepatic or splenic cysts identified.

  


liver/spleen (normal #3) image#1 image #2

Clinical Indications: 26 year old patient w/ hepatitis C - test for liver function.

Dose: 5mCi Tc-99m-albumin colloid.

Results: normal liver/spleen scintigraphy.

  


liver/spleen (abnormal #1)

Clinical Indications: 65 year old white male with an abnormal CT scan of liver, weight loss, abdominal pain and nausea.

Dose: 6mCi Tc-99m-albumin colloid given i.v.

Results: (1) normal sized liver (2) the multiple space-occupying defects and colloid distribution is consistent with metastatic disease to the liver; multicystic liver disease can have this appearance in the appropriate clinical setting.

  


liver/spleen (abnormal #2)

Clinical Indications: 51 year old white female who has a polycystic kidney disease and chronic renal failure.

Dose: 5mCi Tc-99m-albumin colloid given i.v.

Results: multiple decreased uptake areas in the liver which could represent polycystic liver disease.

  


liver/spleen (abnormal #3)

Clinical Indications: 62 year old female with history of hepatitis C, cirrhosis and thrombocytopenia which may be secondary to ITP.

Dose: 6mCi Tc-99m-albumin colloid given i.v.

Results: shrunken left hepatic lobe w/ heterogeneous distribution of activity; normal spleen.


liver/spleen (abnormal #4)

Clinical Indications: 69 year-old white female w/ history of macrocytic anemia and thrombocytopenia - study done to evaluate spleen size.

Dose: 5 mCi Tc-99m-albumin colloid given i.v.

Results: colloid shift of radiopharmaceutical which is consistent with mild hepatocellular disease; normal spleen size without evidence of splenomegaly.

  


liver/spleen (abnormal #5)

Clinical Indications: patient has a history of cirrhosis w/ elevated blood ammonia levels and pancytopenia.

Dose: 5 mCi Tc-99m-albumin colloid given i.v.

Results: findings are described above consistent w/ cirrhosis w/ splenomegaly; there are several photopenic foci, predominantly involving the liver dome; hepatocellular carcinoma or pseudo tumor cannot be excluded.

  


liver/spleen (abnormal #6)

Clinical Indications: 71 year old white female history of alcohol abuse and positive antinuclear antibodies.

Dose: 10mCi Tc-99m-albumin colloid given i.v.

Results: patchy uptake of colloid in liver consistent with fatty infiltration or hepatitis; increased colloid activity in spleen relative to liver suggestive of shunting of portal flow to spleen; borderline hepatomegaly and splenomegaly; no discrete liver or splenic masses.

  


liver/spleen (abnormal #7)

Clinical Indications: 50 year white female patient w/ SLE and APLS - study to rule out accessory spleen.

Dose: 8mCi Tc-99m-albumin colloid given i.v.

Results: normal homogeneous liver visualized; status/post splenectomy; no accessory of residual spleen visualized.